ABNER HERRMAN & BROCK LLC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 49 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
ABNER HERRMAN & BROCK LLC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q2 2024$49
-40.2%
145,5000.0%0.01%
-40.0%
Q1 2024$82
+105.0%
145,5000.0%0.01%
+66.7%
Q4 2023$40
+37.9%
145,5000.0%0.01%
+50.0%
Q3 2023$29
-95.0%
145,500
-48.0%
0.00%
-95.3%
Q2 2023$577
-37.6%
280,0000.0%0.08%
-39.3%
Q1 2023$924
+101.3%
280,0000.0%0.14%
+97.2%
Q4 2022$459
-100.0%
280,0000.0%0.07%
-68.7%
Q3 2022$1,238,000
+69.4%
280,000
+5.7%
0.23%
+80.2%
Q2 2022$731,000
-17.9%
265,0000.0%0.13%
+0.8%
Q1 2022$890,000
-4.5%
265,000
+13.7%
0.12%
+3.3%
Q4 2021$932,000
+37.9%
233,000
+13.7%
0.12%
+27.4%
Q3 2021$676,000
-26.4%
205,000
-15.1%
0.10%
-25.8%
Q2 2021$918,000
-0.8%
241,5000.0%0.13%
-8.6%
Q1 2021$925,000
-15.4%
241,5000.0%0.14%
-17.6%
Q4 2020$1,093,000
-73.1%
241,500
+0.4%
0.17%
-75.2%
Q3 2020$4,069,000
+51.9%
240,500
+0.6%
0.69%
+42.6%
Q2 2020$2,679,000
+930.4%
239,000
+326.4%
0.48%
+715.3%
Q1 2020$260,00056,0500.06%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q2 2022
NameSharesValueWeighting ↓
Perceptive Advisors 400,000$1,068,0000.09%
SABBY MANAGEMENT, LLC 493,191$1,317,0000.07%
GUARDIAN CAPITAL ADVISORS LP 10,000$23,0000.00%
A.R.T. Advisors, LLC 22,758$60,0000.00%
Psagot Value Holdings Ltd. 22,715$61,0000.00%
TCI Wealth Advisors, Inc. 1,100$3,0000.00%
Penserra Capital Management LLC 4,980$13,0000.00%
D'Orazio & Associates, Inc. 500$1,0000.00%
CITIGROUP INC 380$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 61,269$163,0000.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders